| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10741-011-9282-Y |
| P698 | PubMed publication ID | 22002260 |
| P2093 | author name string | Bodh I Jugdutt | |
| Jonathan P Man | |||
| P2860 | cites work | Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group | Q74666357 |
| Diuretic therapy | Q74837382 | ||
| Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial | Q78061912 | ||
| Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations | Q78961041 | ||
| Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials | Q81552190 | ||
| Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation | Q83582548 | ||
| Safety and effectiveness of primary prevention cardioverter defibrillators in octogenarians | Q83717597 | ||
| Effectiveness of guideline-recommended cardiac drugs for reducing mortality in the elderly medicare heart failure population: a retrospective, survey-weighted, cohort analysis | Q85114267 | ||
| Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association | Q22306345 | ||
| 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults | Q28239484 | ||
| Combination of isosorbide dinitrate and hydralazine in blacks with heart failure | Q28292266 | ||
| A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure | Q28328342 | ||
| Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group | Q28342399 | ||
| The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
| Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) | Q28378044 | ||
| ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Gui | Q33156283 | ||
| Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group | Q33157410 | ||
| Effects of self-management intervention on health outcomes of patients with heart failure: a systematic review of randomized controlled trials | Q33262511 | ||
| Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema | Q33895248 | ||
| Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. | Q33895894 | ||
| A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure | Q34106793 | ||
| HFSA 2010 Comprehensive Heart Failure Practice Guideline | Q34124756 | ||
| Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction | Q34187441 | ||
| Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial | Q34246891 | ||
| Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial | Q34246898 | ||
| Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment | Q34316758 | ||
| The acute effects of a single dopamine infusion in elderly patients with congestive cardiac failure. | Q34346128 | ||
| High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese | Q34347605 | ||
| Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology | Q34450874 | ||
| Cardiac resynchronization in chronic heart failure | Q34524008 | ||
| Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction | Q34738402 | ||
| Cardiovascular drug therapy in the elderly: theoretical and practical considerations | Q35113299 | ||
| Patterns of pharmacologic treatment of congestive heart failure in elderly nursing home residents and related issues: a review of the literature | Q35208543 | ||
| Systematic review of multidisciplinary interventions in heart failure. | Q35584426 | ||
| Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. | Q35863540 | ||
| A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure | Q35959146 | ||
| Office management of heart failure in the elderly | Q36088474 | ||
| Cognitive impairment in heart failure: a systematic review of the literature | Q36686297 | ||
| Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006 | Q37067113 | ||
| Aging and remodeling during healing of the wounded heart: current therapies and novel drug targets | Q37130706 | ||
| Current and novel cardiac support therapies | Q37407712 | ||
| Guided care and the cost of complex healthcare: a preliminary report. | Q37577888 | ||
| A review of heart failure management in the elderly population | Q37641481 | ||
| Aging and heart failure: changing demographics and implications for therapy in the elderly | Q37724012 | ||
| Heart failure in the elderly: advances and challenges | Q37744960 | ||
| Geriatric care management for low-income seniors: a randomized controlled trial | Q38393323 | ||
| The epidemiology of heart failure: the Framingham Study | Q38512101 | ||
| Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Ger | Q40213069 | ||
| Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. | Q40470495 | ||
| Diuretic treatment for the sodium retention of congestive heart failure | Q40696314 | ||
| Clinical epidemiology of heart failure: public and private health burden | Q40829008 | ||
| Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure | Q42206347 | ||
| Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure | Q43489268 | ||
| Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications | Q43545314 | ||
| Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study | Q44044871 | ||
| Decisions about resuscitation: inequities among patients with different diseases but similar prognoses | Q44118928 | ||
| Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications | Q44169479 | ||
| Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study | Q44371716 | ||
| Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study | Q44485270 | ||
| Mild renal insufficiency and risk of congestive heart failure in men and women > or =70 years of age. | Q44583585 | ||
| Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure | Q45002968 | ||
| The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure | Q45025646 | ||
| Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study | Q45337067 | ||
| Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. | Q46184662 | ||
| A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications | Q46577613 | ||
| Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy | Q46916919 | ||
| Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. | Q50869152 | ||
| Outcomes of elective versus emergent permanent mechanical circulatory support in the elderly: a single-center experience. | Q52905776 | ||
| Determinants of mortality in elderly patients with heart failure: the role of angiotensin-converting enzyme inhibitors. | Q52905901 | ||
| Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. | Q53386603 | ||
| Variable furosemide absorption and poor predictability of response in elderly patients. | Q53977479 | ||
| Comparison of the Usefulness of Cardiac Resynchronization Therapy in Three Age-Groups (<65, 65-74 and ≥75 Years) (from the InSync/InSync ICD Italian Registry) | Q58819165 | ||
| Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure | Q62023674 | ||
| Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group | Q68426735 | ||
| Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure | Q70223239 | ||
| Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study | Q70746802 | ||
| Postural hypotension and tachycardia during hydralazine--isosorbide dinitrate therapy for chronic heart failure | Q71532933 | ||
| Association of serum digoxin concentration and outcomes in patients with heart failure | Q73004928 | ||
| The effect of digoxin on mortality and morbidity in patients with heart failure | Q73080377 | ||
| Predictors of survival in patients bridged to transplantation with the thoratec VAD device: a single-center retrospective study on more than 100 patients | Q73109453 | ||
| Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial | Q73173183 | ||
| Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome | Q73513246 | ||
| Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure | Q74530472 | ||
| P433 | issue | 4-5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| systole | Q496359 | ||
| systolic heart failure | Q17326470 | ||
| P304 | page(s) | 563-571 | |
| P577 | publication date | 2012-09-01 | |
| P1433 | published in | Heart Failure Reviews | Q2167497 |
| P1476 | title | Systolic heart failure in the elderly: optimizing medical management | |
| P478 | volume | 17 |
| Q40079427 | A systematic review of diagnostic methods to differentiate acute lung injury/acute respiratory distress syndrome from cardiogenic pulmonary edema. |
| Q36128797 | Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF. |
| Q35844522 | Exploration of Pharmacophore in Chrysosplenol C as Activator in Ventricular Myocyte Contraction. |
| Q34930544 | Management of chronic heart failure in the older population |
| Q38057693 | Treatment for chronic heart failure in the elderly: current practice and problems |
Search more.